JP2016512501A5 - - Google Patents

Download PDF

Info

Publication number
JP2016512501A5
JP2016512501A5 JP2016500869A JP2016500869A JP2016512501A5 JP 2016512501 A5 JP2016512501 A5 JP 2016512501A5 JP 2016500869 A JP2016500869 A JP 2016500869A JP 2016500869 A JP2016500869 A JP 2016500869A JP 2016512501 A5 JP2016512501 A5 JP 2016512501A5
Authority
JP
Japan
Prior art keywords
butoxy
tert
alkyl
acetic acid
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016500869A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016512501A (ja
JP6268656B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/021867 external-priority patent/WO2014159076A1/en
Publication of JP2016512501A publication Critical patent/JP2016512501A/ja
Publication of JP2016512501A5 publication Critical patent/JP2016512501A5/ja
Application granted granted Critical
Publication of JP6268656B2 publication Critical patent/JP6268656B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016500869A 2013-03-14 2014-03-07 ヒト免疫不全ウイルス複製の阻害剤 Expired - Fee Related JP6268656B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361781315P 2013-03-14 2013-03-14
US61/781,315 2013-03-14
PCT/US2014/021867 WO2014159076A1 (en) 2013-03-14 2014-03-07 Inhibitors of human immunodeficiency virus replication

Publications (3)

Publication Number Publication Date
JP2016512501A JP2016512501A (ja) 2016-04-28
JP2016512501A5 true JP2016512501A5 (cg-RX-API-DMAC7.html) 2017-03-09
JP6268656B2 JP6268656B2 (ja) 2018-01-31

Family

ID=50439486

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016500869A Expired - Fee Related JP6268656B2 (ja) 2013-03-14 2014-03-07 ヒト免疫不全ウイルス複製の阻害剤

Country Status (5)

Country Link
US (1) US9540393B2 (cg-RX-API-DMAC7.html)
EP (1) EP2970297A1 (cg-RX-API-DMAC7.html)
JP (1) JP6268656B2 (cg-RX-API-DMAC7.html)
CN (1) CN105008369B (cg-RX-API-DMAC7.html)
WO (1) WO2014159076A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015123182A1 (en) * 2014-02-12 2015-08-20 Bristol-Myers Squibb Company Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication
US9409922B2 (en) 2014-02-18 2016-08-09 Bristol-Myers Squibb Company Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication
US9273067B2 (en) * 2014-02-19 2016-03-01 Bristol-Myers Squibb Company Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication
CN116005285B (zh) * 2022-12-26 2025-03-25 广东蒙泰高新纤维股份有限公司 一种抗紫外回收餐盒聚丙烯纤维的制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7939545B2 (en) 2006-05-16 2011-05-10 Boehringer Ingelheim International Gmbh Inhibitors of human immunodeficiency virus replication
PT2054416E (pt) 2006-08-04 2011-04-06 Merz Pharma Gmbh & Co Kgaa Pirazolopirimidinas substituídas, um processo para a sua preparação e a sua utilização como medicamento
EP2574610A1 (en) 2007-11-15 2013-04-03 Gilead Sciences, Inc. Inhibitors of human immonodeficiency virus replication
HRP20120328T2 (hr) 2007-11-15 2012-09-30 Gilead Sciences Inhibitori replikacije virusa humane imunodeficijencije
KR20100097156A (ko) 2007-11-16 2010-09-02 베링거 인겔하임 인터내셔날 게엠베하 사람 면역결핍 바이러스 복제의 억제제
CA2705338A1 (en) 2007-11-16 2009-05-22 Boehringer Ingelheim International Gmbh Inhibitors of human immunodeficiency virus replication
WO2009066228A1 (en) 2007-11-23 2009-05-28 Koninklijke Philips Electronics N.V. Compartment
TW200942243A (en) * 2008-03-05 2009-10-16 Biocryst Pharm Inc Antiviral therapeutic agents
US8129398B2 (en) * 2008-03-19 2012-03-06 Bristol-Myers Squibb Company HIV integrase inhibitors
US8338441B2 (en) 2009-05-15 2012-12-25 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
CA2781780C (en) 2009-12-23 2015-02-17 Katholieke Universiteit Leuven Novel antiviral compounds
NZ604716A (en) 2010-07-02 2014-12-24 Gilead Sciences Inc 2-quinolinyl-acetic acid derivatives as hiv antiviral compounds
MA34397B1 (fr) 2010-07-02 2013-07-03 Gilead Sciences Inc Dérivés d'acide napht-2-ylacétique dans le traitement du sida
US8633200B2 (en) * 2010-09-08 2014-01-21 Bristol-Myers Squibb Company Inhibitors of human immunodeficiency virus replication
AU2011330850B2 (en) 2010-11-15 2016-01-28 Viiv Healthcare Uk Limited Inhibitors of HIV replication
MX2013005478A (es) 2010-11-15 2013-08-29 Univ Leuven Kath Compuestos heterociclicos condensados antivirales.
PL2710018T3 (pl) * 2011-05-19 2022-04-04 Fundación Del Sector Público Estatal Centro Nacional De Investigaciones Oncológicas Carlos III (F.S.P. CNIO) Związki makrocykliczne jako inhibitory kinaz białkowych
US8791108B2 (en) * 2011-08-18 2014-07-29 Bristol-Myers Squibb Company Inhibitors of human immunodeficiency virus replication
US8906929B2 (en) * 2012-08-16 2014-12-09 Bristol-Myers Squibb Company Inhibitors of human immunodeficiency virus replication

Similar Documents

Publication Publication Date Title
PH12021500049A1 (en) 2,3-dihydroquinazolin compounds as nav1.8 inhibitors
JP2016512558A5 (cg-RX-API-DMAC7.html)
JP2015524841A5 (cg-RX-API-DMAC7.html)
JP2016512507A5 (cg-RX-API-DMAC7.html)
JP2016516692A5 (cg-RX-API-DMAC7.html)
JP2013531029A5 (cg-RX-API-DMAC7.html)
HRP20241553T1 (hr) 4-(4-(4-(((2-(2,6-dioksopiperidin-3-il)-l-oksoizoindolin-4-il)oksi)metil)benzil)piperazin-l-il)-3-fluorobenzonitril kao antiproliferativni spoj
JP2016512511A5 (cg-RX-API-DMAC7.html)
JP2016506961A5 (cg-RX-API-DMAC7.html)
SI3024819T1 (en) Glyoxamide-substituted pyrrolamide derivatives and their use as medicines for the treatment of hepatitis B
JP2016506962A5 (cg-RX-API-DMAC7.html)
JP2016528301A5 (cg-RX-API-DMAC7.html)
PE20161218A1 (es) (2s)-n-[(1s)-1-ciano-2-feniletil]-1,4-oxazepan-2-carboxamidas como inhibidores de dipeptidil peptidasa 1
NZ708593A (en) Novel pyrazole derivative
JP2018522927A5 (cg-RX-API-DMAC7.html)
JP2017537949A5 (cg-RX-API-DMAC7.html)
MX2020001717A (es) Inhibidores macrociclicos de mcl-1 y metodos de uso.
JP2020507589A5 (cg-RX-API-DMAC7.html)
UA115881C2 (uk) Алкоксипіразоли як активатори розчинної гуанілатциклази
JP2017526677A5 (cg-RX-API-DMAC7.html)
JP2017526748A5 (cg-RX-API-DMAC7.html)
IL257240A (en) History of 5– (n– benzyl tetrahydroisoquinoline – 6 – il) Pyridine – 3 – il Acetic acid as inhibitors of human immunodeficiency virus replication
GEP20237476B (en) N-substituted-dioxocyclobutenylamino-3-hydroxypicolinamides useful as ccr6 inhibitors
JP2016512501A5 (cg-RX-API-DMAC7.html)
RU2017107715A (ru) Производные имидазо[1,2-a]пиридина для применения в качестве ингибиторов репликации вируса иммунодефицита человека